Townsend Richard Nolan
Insider CIK 1995218 · LXEO Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2026-09-24 | 2026-09-28 | 145,500 | — | $0 | 145,500 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2026-09-24 | 2026-09-28 | 145,500 | — | $0 | 145,500 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award | 2026-09-14 | 2026-09-28 | 2,306 | $2.64 | $6.1K | 376,778 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award | 2026-09-14 | 2026-09-28 | 2,306 | $2.64 | $6.1K | 376,778 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-19 | 3,345 | $4.95 | $16.6K | 374,472 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-19 | 3,345 | $4.95 | $16.6K | 374,472 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2026-07-01 | 2026-07-01 | 25,947 | $4.48 | $116.2K | 377,817 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award | 2026-06-29 | 2026-07-01 | 67,000 | — | $0 | 403,764 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2026-05-18 | 2026-05-20 | 3,342 | $5.06 | $16.9K | 336,764 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2026-04-06 | 2026-04-07 | 55,000 | $5.69 | $312.9K | 340,106 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award | 2026-03-13 | 2026-03-17 | 2,623 | $2.64 | $6.9K | 395,106 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2026-02-18 | 2026-02-20 | 10,173 | $6.38 | $64.9K | 392,483 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2026-02-04 | 2026-02-06 | 646,665 | — | $0 | 646,665 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award | 2026-02-04 | 2026-02-06 | 161,665 | — | $0 | 402,656 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2025-11-18 | 2025-11-20 | 1,127 | $9.27 | $10.4K | 240,991 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2025-10-17 | 2025-10-17 | 148 | $9.56 | $1.4K | 242,118 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2025-10-17 | 2025-10-17 | 12,985 | $8.94 | $116.1K | 242,266 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award | 2025-10-15 | 2025-10-17 | 33,000 | — | $0 | 255,251 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award | 2025-09-12 | 2025-09-16 | 2,193 | $2.64 | $5.8K | 222,251 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2025-08-18 | 2025-08-20 | 2,735 | $4.67 | $12.8K | 220,058 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2025-08-18 | 2025-09-10 | 1,115 | $4.67 | $5.2K | 220,058 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2025-05-16 | 2025-05-20 | 1,074 | $2.77 | $3.0K | 221,173 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award | 2025-03-14 | 2025-04-01 | 2,128 | $2.61 | $5.6K | 222,247 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2025-02-19 | 2025-02-21 | 4,326 | $4.41 | $19.1K | 220,119 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2025-01-07 | 2025-01-10 | 207,500 | — | $0 | 207,500 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award | 2025-01-07 | 2025-01-10 | 103,750 | — | $0 | 224,445 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise deriv | 2024-12-10 | 2024-12-12 | 2,500 | — | $0 | 118,655 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2024-12-10 | 2024-12-12 | 2,500 | $8.20 | $20.5K | 120,695 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise | 2024-12-10 | 2024-12-12 | 2,500 | $2.33 | $5.8K | 123,195 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise deriv | 2024-11-11 | 2024-11-13 | 2,500 | — | $0 | 121,155 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise | 2024-11-11 | 2024-11-13 | 2,500 | $2.33 | $5.8K | 123,195 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2024-11-11 | 2024-11-13 | 2,500 | $7.82 | $19.6K | 120,695 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise deriv | 2024-10-10 | 2024-10-15 | 5,000 | — | $0 | 123,655 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2024-10-10 | 2024-10-15 | 5,000 | $8.10 | $40.5K | 120,695 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise | 2024-10-10 | 2024-10-15 | 5,000 | $2.33 | $11.7K | 125,695 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise deriv | 2024-09-10 | 2024-09-11 | 5,000 | — | $0 | 128,655 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise | 2024-09-10 | 2024-09-11 | 5,000 | $2.33 | $11.7K | 125,695 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-11 | 5,000 | $10.65 | $53.3K | 120,695 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise deriv | 2024-08-12 | 2024-08-13 | 5,000 | — | $0 | 133,655 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise | 2024-08-12 | 2024-08-13 | 5,000 | $2.33 | $11.7K | 125,695 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2024-08-12 | 2024-08-13 | 5,000 | $11.53 | $57.6K | 120,695 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2024-07-11 | 2024-07-12 | 27,931 | $17.06 | $476.5K | 120,795 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2024-07-11 | 2024-07-12 | 100 | $19.06 | $1.9K | 120,695 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise deriv | 2024-07-10 | 2024-07-12 | 5,000 | — | $0 | 138,655 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2024-07-10 | 2024-07-12 | 3,347 | $16.85 | $56.4K | 148,726 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2024-07-10 | 2024-07-12 | 23,622 | $16.45 | $388.6K | 152,073 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise | 2024-07-10 | 2024-07-12 | 5,000 | $2.33 | $11.7K | 175,695 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise deriv | 2024-06-10 | 2024-06-12 | 5,000 | — | $0 | 143,655 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2024-06-10 | 2024-06-12 | 2,038 | $18.18 | $37.1K | 170,695 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2024-06-10 | 2024-06-12 | 2,962 | $17.29 | $51.2K | 172,733 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise | 2024-06-10 | 2024-06-12 | 5,000 | $2.33 | $11.7K | 175,695 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise deriv | 2024-05-13 | 2024-05-14 | 5,000 | $2.33 | $11.7K | 148,655 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | M Exercise | 2024-05-13 | 2024-05-14 | 5,000 | $2.33 | $11.7K | 175,695 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | S Sale | 2024-05-13 | 2024-05-14 | 5,000 | $13.22 | $66.1K | 170,695 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award deriv | 2024-01-05 | 2024-01-09 | 262,500 | — | $0 | 262,500 | SEC↗ |
| LXEO Lexeo Therapeutics, Inc. | A Award | 2024-01-05 | 2024-01-09 | 43,750 | — | $0 | 170,695 | SEC↗ |